PCR-Based Diagnostics With Empiric Antibiotic Selection
OwnerBrian Joseph Hajjarinventor
Life of this patent
Estimating the term…
Abstract
The present invention allows for early diagnosis and treatment of an infection using a molecular amplification method with API integration to a database of recommended antimicrobial agents. The method which may be a PCR-based technique determines a microorganism in a biological sample and provides a concurrent determination of empiric antibiotic therapy.
Claims20
A method for identifying a microorganism in a biological sample comprising:
- obtaining a biological sample from a patient suspected of being infected with a pathogen;
- extracting DNA from the sample;
- performing molecular amplification analysis;
- identifying one or more pathogens;
- conducting API integration with an empiric antibiotic database;
- and
- identifying empiric antibiotic therapy.
A method for analyzing a biological sample for pathogens comprising using a PCR-technology platform linked via API integration to a database of empiric antimicrobial regimens.
A method of identifying a microorganism in a biological sample comprising:
- a biologic specimen is collected from a patient;
- DNA is extracted from a cell and subject to a PCR amplification process;
- one or more pathogens are identified;
- API integration with the Laboratory Information Management System (LIMS) system;
- the identified pathogen is processed in LIMS;
- API integration with an empiric antimicrobial database identifies the pathogen and the necessary sensitivity and resistance;
- the LIMS system integrates details that correspond with the pathogen present onto a report;
- and
- the report is generated and sent to a physician or a patient for review
Dependencies are inferred from the claim text.